Production of transgenic rats for human regulators of complement activation.
Charreau
B
B
ITERT INSERM U 437, Nantes, France.
Tesson
L
L
Menoret
S
S
Buscail
J
J
Soulillou
J P
JP
Anegon
I
I
D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000096:biosynthesis*; D001402:B-Lymphocytes / Q000276:immunology; D018958:CD55 Antigens / Q000096:biosynthesis*; D018957:CD59 Antigens / Q000096:biosynthesis*; D003167:Complement Activation; D004624:Embryo Transfer; D005260:Female; D006801:Humans; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D013154:Spleen / Q000276:immunology; D013480:Superovulation; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014183:Transplantation, Heterologous / Q000276:immunology*
D015703:Antigens, CD; D018958:CD55 Antigens; D018957:CD59 Antigens